ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 69.10
+2.90 (4.38%)
At close: Dec 5, 2025
ACRO Biomedical Revenue
ACRO Biomedical had revenue of 13.32M TWD in the half year ending June 30, 2025, a decrease of -15.74%. This brings the company's revenue in the last twelve months to 36.50M, down -35.18% year-over-year. In the year 2024, ACRO Biomedical had annual revenue of 44.23M, down -13.38%.
Revenue (ttm)
36.50M
Revenue Growth
-35.18%
P/S Ratio
115.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.23M | -6.83M | -13.38% |
| Dec 31, 2023 | 51.06M | 23.43M | 84.79% |
| Dec 31, 2022 | 27.63M | 5.81M | 26.59% |
| Dec 31, 2021 | 21.83M | 3.80M | 21.04% |
| Dec 31, 2020 | 18.03M | 10.71M | 146.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |